• Thurs news: Lilly’s weight-loss drug prevents diabetes. Merck pays $588M for bispecific. Amgen speaks out about bone density issues with obesity drug. PTC gets gene therapy approval. JNJ’s 340B legal fight. See more on our front page

Ophthalmology

Anonymous board for Ophthalmology reps
Replies
14
Views
13K
anonymous
Replies
37
Views
18K
anonymous
Replies
11
Views
952
anonymous
Replies
6
Views
506
anonymous
Replies
37
Views
5K
anonymous
Replies
2
Views
485
anonymous
Replies
0
Views
952
anonymous
Replies
4
Views
6K
anonymous
Replies
12
Views
9K
anonymous
Replies
6
Views
3K
anonymous
Replies
192
Views
48K
anonymous
Replies
2
Views
2K
anonymous
Replies
0
Views
401
anonymous
Replies
0
Views
781
anonymous
Replies
0
Views
841
anonymous
Replies
11
Views
9K
anonymous
Replies
1
Views
1K
anonymous
Replies
4
Views
6K
anonymous
Replies
2
Views
4K
anonymous
Replies
4
Views
5K
anonymous